Announce Date | 02/05/2025 |
EPS Normalized Actual | $0.08 (Beat by $0.03) |
EPS GAAP Actual | $0.08 (Beat by $0.03) |
Revenue Actual | $0.14751B |
Revenue Surprise | Beat by $147.51M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.05 |
EPS GAAP Estimate | $0.05 |
Revenue Estimate | $0.170228533B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 1.46 | 26.57 | 1.44962 | 1.47051 | 1 |
Sep 2028 | 1.07 | 36.25 | 1.06207 | 1.07737 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.29 | -0.29 | 0.14751B | -4.61% | 147.51M |
FQ3 2024 (Sep 2024) | 0 | 0 | 0.170063B | -1.35% | 170.06M |
FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 0.172809B | 3.97% | 172.81M |
FQ1 2024 (Mar 2024) | -2.47 | -2.47 | 0.159134B | 6.74% | 159.13M |
FQ4 2023 (Dec 2023) | -0.28 | -0.28 | 0.154317B | -15.58% | 154.32M |
FQ3 2023 (Sep 2023) | 0.06 | 0.06 | 0.172357B | 20.18% | 172.36M |
FQ2 2023 (Jun 2023) | -0.0232 | -0.0232 | 0.165948B | 20.01% | 165.95M |
FQ1 2023 (Mar 2023) | -0.0713 | -0.0713 | 0.148401B | 100% | 148.4M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
0.05
Consensus Revenue Estimates
0.170228533B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 0.27 | -- | 0.27 | 0.27 | 1 |
FQ1 2027 (Mar 2027) | 0.22 | -- | 0.22 | 0.22 | 1 |
FQ4 2026 (Oct 2026) | 0.31 | -- | 0.29194 | 0.34183 | 1 |
FQ3 2026 (Jul 2026) | 0.255 | -- | 0.24015 | 0.28119 | 1 |
FQ2 2026 (Jun 2026) | 0.255 | -- | 0.24907 | 0.26139 | 0 |
FQ1 2026 (Mar 2026) | 0.17 | -- | 0.16605 | 0.17426 | 0 |
FQ4 2025 (Oct 2025) | 0.1725 | 268.12 | 0.16245 | 0.19021 | 2 |
FQ3 2025 (Jul 2025) | 0.1275 | -- | 0.12007 | 0.14059 | 2 |
FQ2 2025 (Jun 2025) | 0.13 | 192.31 | 0.12698 | 0.13326 | 1 |
FQ1 2025 (Mar 2025) | 0.05 | 5040 | 0.04883742 | 0.05125359 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 0.2B | -- | 0.2B | 0.2B | 2 |
FQ1 2027 (Mar 2027) | 0.19B | -- | 0.19B | 0.19B | 2 |
FQ4 2026 (Oct 2026) | 0.2B | -- | 0.2B | 0.22B | 2 |
FQ3 2026 (Jul 2026) | 0.19B | -- | 0.19B | 0.21B | 2 |
FQ2 2026 (Jun 2026) | 0.19B | -- | 0.19B | 0.2B | 2 |
FQ1 2026 (Mar 2026) | 0.18B | -- | 0.18B | 0.18B | 2 |
FQ4 2025 (Oct 2025) | 0.19B | 23.62 | 0.18B | 0.21B | 1 |
FQ3 2025 (Jul 2025) | 0.18B | 4.5 | 0.17B | 0.19B | 1 |
FQ2 2025 (Jun 2025) | 0.19B | 6.87 | 0.18B | 0.19B | 1 |
FQ1 2025 (Mar 2025) | 0.17B | 6.52 | 0.17B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.29 | -0.29 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 100% | |
FQ1 2024 (Mar 2024) | -2.47 | -2.47 | 100% | |
FQ4 2023 (Dec 2023) | -0.28 | -0.28 | 100% | |
FQ3 2023 (Sep 2023) | 0.06 | 0.06 | 100% | |
FQ2 2023 (Jun 2023) | -0.0232 | -0.0232 | 100% | |
FQ1 2023 (Mar 2023) | -0.0713 | -0.0713 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.15B | $147.51M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.17B | $170.06M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.17B | $172.81M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.16B | $159.13M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.15B | $154.32M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.17B | $172.36M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.17B | $165.95M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.15B | $148.4M | 100% |